By Deena Beasley(Reuters) -U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs would likely be absorbed by drugmakers rather than patients whose payments are often set by health insurance.U.S. health insurers, which pay the bulk of prescription drug costs, act as a buffer between drugmakers and patients, with beneficiaries su ...
Investing.com -- Mizuho upgraded Cloudflare Inc (NYSE:NET) to “Outperform,” citing strengthening sales pipelines, rising adoption of its Workers AI product, and a favorable setup for growth reacceleration in the second half of 2025.“Our recent checks on NET were more favorable than we expected,” the analysts wrote, highlighting large-deal activity and growing momentum for AI inferen ...
By Christy Santhosh and Puyaan Singh(Reuters) -Medical device maker Abbott Laboratories (NYSE:ABT) maintained its annual profit forecast on Wednesday and said it expected the U.S. tariffs to hit earnings by a "few hundred million dollars".Shares rose 6% in morning trade, as the company also announced $500 million in new investments in manufacturing and research projects in Illinois and Texas.The ...
Investing.com -- JP Morgan downgraded U.S. Steel to “Neutral” from “Overweight” and cut its price target to $38 from $43, citing softening demand outlook, potential auto-related tariff risks, and uncertainty around the pending takeover by Japan’s Nippon Steel.The firm said it expects construction demand to face pressure, while auto and appliance demand remain stable near term. Howev ...